UnknownNot Applicable

Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR)

France60 participantsStarted 2023-01-16

Plain-language summary

Prospective, nonrandomized, single-center, comparative study to define if right ventricular (RV) contractile reserve assessed by exercise CMR helps to improve the differential diagnosis between pathological and physiological remodeling of the RV; ie. arrhythmogenic right ventricular cardiomyopathy (ARVC) and athlete's heart.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men or women aged 18 years and older, * patients with confirmed ARVC, but with no major RV dysfunction (RVEF \>40%) * endurance athletes with dilated RV * endurance athletes with non-dilated RV * untrained healthy subjects with non-dilated RV * who signed a written free and informed consent: Exclusion Criteria: * Patients with other cardiovascular disease; * Contra-indication to CMR (in particular presence of a non-CMR compatible implantable cardiac defibrillator); * Patients with permanent supraventricular arrhythmia; * Patients unable to perform an exercise test on an ergocycle; * Person subject to legal protection (safeguard justice, trusteeship and guardianship) and persons deprived of liberty

What they're measuring

Evolution of right ventricular ejection fraction (RVEF) assessed with CMR during exercise

Timeframe: Through study completion, an average of 1 month

Trial details

NCT IDNCT05024708

SponsorRennes University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-16

Contact for this trial

Frédéric SCHNELL, MD-PhD

+33 2.99.28.41.33 Frederic.SCHNELL@chu-rennes.fr

View on ClinicalTrials.gov More Arrhythmogenic Right Ventricular Cardiomyopathy trials